This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 February 2018 and includes updates on poliomyelitis, hepatitis A, seasonal influenza, rubella, measles, meningitis, mass gathering monitoring (Olympics) and yellow fever.
In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.
This expert opinion is intended to support national decision-making by summarising the considerations and concerns of some EU/EEA countries when they discussed whether to introduce the 4CMenB vaccine into their national immunisation programmes.